Background: Treatment of latent tuberculosis infection (LTBI) is an important component of
tuberculosis (TB) control, and this study updates a previous network meta-analysis of the …

Context Latent tuberculosis infection diagnosis and treatment is a strategic priority for
eliminating tuberculosis in the US The Centers for Disease Control and Prevention has …

About one fourth of the world's population is estimated to be infected with M. tuberculosis (1,
2). The risk of TB disease after infection depends on several factors, the most important …

Background Guidelines and implementation of tuberculosis preventive treatment (TPT) vary
by age and HIV status. Specifically, TPT is strongly recommended for people living with …

Background Tuberculosis (TB) preventive therapy (TPT) is an essential component of care
for people living with HIV (PLHIV). We compared efficacy, safety, completion, and drug …

A once-weekly oral dose of isoniazid and rifapentine for 3 months (3HP) is recommended by
the CDC for treatment of latent tuberculosis infection (LTBI). The aim of this study is to …

Tuberculosis (TB) preventive therapy (TPT) is an effective strategy to eliminate TB in low-
incidence settings. Shorter TPT regimens incorporating the antimicrobial class of rifamycins …

Background Treatment of latent tuberculosis infection (LTBI) is effective in preventing
progression to TB disease. This study aimed to synthesize available evidence on the …

Purpose Tuberculosis (TB) remains a common cause of death globally. A regimen of 12
doses of isoniazid (INH) and rifapentine given once weekly (INH/RPT‐3) has recently been …

Despite the availability of three network meta-analyses (NMA) examining the efficacy,
treatment completion, and adverse events associated with all latent tuberculosis infection …